ID

36571

Descripción

A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01615406

Link

https://clinicaltrials.gov/show/NCT01615406

Palabras clave

Versiones (3)
  1. 17/1/19 17/1/19 -
  2. 22/5/19 22/5/19 -
  3. 23/5/19 23/5/19 - Sarah Riepenhausen
Titular de derechos de autor

Molecular Insight Pharmaceuticals, Inc.

Subido en

22 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Comparing 99mTc-MIP-1404 SPECT/CT to Histology in Prostate Cancer NCT01615406

Inglés

Eligibility

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male aged 21 years or older
Descripción

Gender and Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
ability to provide signed informed consent and willingness to comply with protocol requirements.
Descripción

Informed consent and compliance with protocol requirements

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
past biopsy indicating the presence of adenocarcinoma of the prostate gland
Descripción

past biopsy indicating the presence of adenocarcinoma of the prostate gland

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007112
UMLS CUI [1,2]
C0205156
UMLS CUI [1,3]
C0005558
participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection.
Descripción

participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040300
UMLS CUI [1,2]
C0242114
UMLS CUI [1,3]
C0600139
UMLS CUI [1,4]
C3900053
UMLS CUI [1,5]
C0005558
UMLS CUI [2,1]
C0040300
UMLS CUI [2,2]
C0242114
UMLS CUI [2,3]
C0600139
UMLS CUI [2,4]
C3900053
UMLS CUI [2,5]
C0728940
have had, or will undergo diagnostic CT or MRI imaging prior to surgery
Descripción

diagnostic CT or MRI prior to surgery

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301732
UMLS CUI [1,2]
C0011923
UMLS CUI [1,3]
C0040405
UMLS CUI [1,4]
C0332152
UMLS CUI [1,5]
C0543467
UMLS CUI [2,1]
C1301732
UMLS CUI [2,2]
C0011923
UMLS CUI [2,3]
C0917711
UMLS CUI [2,4]
C0332152
UMLS CUI [2,5]
C0543467
UMLS CUI [3,1]
C0205156
UMLS CUI [3,2]
C0011923
UMLS CUI [3,3]
C0040405
UMLS CUI [3,4]
C0332152
UMLS CUI [3,5]
C0543467
UMLS CUI [4,1]
C0205156
UMLS CUI [4,2]
C0011923
UMLS CUI [4,3]
C0917711
UMLS CUI [4,4]
C0332152
UMLS CUI [4,5]
C0543467
participants must agree to use an acceptable form of birth control throughout the study period. participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity.
Descripción

Agreeing to acceptable birth control throughout study and using condoms after study drug administration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C2347804
UMLS CUI [1,3]
C3641827
UMLS CUI [2,1]
C0679782
UMLS CUI [2,2]
C0580203
UMLS CUI [2,3]
C3469597
UMLS CUI [2,4]
C0304229
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
participants for whom participating would significantly delay the scheduled standard of care therapy
Descripción

Participating would significantly delay the scheduled standard of care therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0205421
UMLS CUI [1,4]
C2936643
participants administered a radioisotope within 5 physical half lives prior to study enrollment
Descripción

Recent administration of radioisotope

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C1533734
UMLS CUI [1,3]
C0034595
UMLS CUI [2]
C0259911
participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study
Descripción

Medical condition or other circumstances impeding obtaining reliable data, achieving study objectives or completing study

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C3858758
UMLS CUI [1,4]
C0681873
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C2985627
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C2348577
UMLS CUI [4,1]
C0680082
UMLS CUI [4,2]
C0392760
UMLS CUI [4,3]
C3858758
UMLS CUI [4,4]
C0681873
UMLS CUI [5,1]
C0680082
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C2985627
UMLS CUI [6,1]
C0680082
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C2348577
Volver a la parte superior de la página

Similar models

Eligibility

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender and Age
Item
male aged 21 years or older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Informed consent and compliance with protocol requirements
Item
ability to provide signed informed consent and willingness to comply with protocol requirements.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
past biopsy indicating the presence of adenocarcinoma of the prostate gland
Item
past biopsy indicating the presence of adenocarcinoma of the prostate gland
boolean
C0007112 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection
Item
participant is deemed to have tissue suspicious of prostate cancer involvement that is amenable to biopsy/resection.
boolean
C0040300 (UMLS CUI [1,1])
C0242114 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C3900053 (UMLS CUI [1,4])
C0005558 (UMLS CUI [1,5])
C0040300 (UMLS CUI [2,1])
C0242114 (UMLS CUI [2,2])
C0600139 (UMLS CUI [2,3])
C3900053 (UMLS CUI [2,4])
C0728940 (UMLS CUI [2,5])
diagnostic CT or MRI prior to surgery
Item
have had, or will undergo diagnostic CT or MRI imaging prior to surgery
boolean
C1301732 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,4])
C0543467 (UMLS CUI [1,5])
C1301732 (UMLS CUI [2,1])
C0011923 (UMLS CUI [2,2])
C0917711 (UMLS CUI [2,3])
C0332152 (UMLS CUI [2,4])
C0543467 (UMLS CUI [2,5])
C0205156 (UMLS CUI [3,1])
C0011923 (UMLS CUI [3,2])
C0040405 (UMLS CUI [3,3])
C0332152 (UMLS CUI [3,4])
C0543467 (UMLS CUI [3,5])
C0205156 (UMLS CUI [4,1])
C0011923 (UMLS CUI [4,2])
C0917711 (UMLS CUI [4,3])
C0332152 (UMLS CUI [4,4])
C0543467 (UMLS CUI [4,5])
Agreeing to acceptable birth control throughout study and using condoms after study drug administration
Item
participants must agree to use an acceptable form of birth control throughout the study period. participants must use condoms for a period of seven days after study drug administration, if engaged in sexual activity.
boolean
C0700589 (UMLS CUI [1,1])
C2347804 (UMLS CUI [1,2])
C3641827 (UMLS CUI [1,3])
C0679782 (UMLS CUI [2,1])
C0580203 (UMLS CUI [2,2])
C3469597 (UMLS CUI [2,3])
C0304229 (UMLS CUI [2,4])
Item Group
C0680251 (UMLS CUI)
Participating would significantly delay the scheduled standard of care therapy
Item
participants for whom participating would significantly delay the scheduled standard of care therapy
boolean
C2348568 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0205421 (UMLS CUI [1,3])
C2936643 (UMLS CUI [1,4])
Recent administration of radioisotope
Item
participants administered a radioisotope within 5 physical half lives prior to study enrollment
boolean
C0332185 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C0034595 (UMLS CUI [1,3])
C0259911 (UMLS CUI [2])
Medical condition or other circumstances impeding obtaining reliable data, achieving study objectives or completing study
Item
participants with any medical condition or other circumstances that, in the opinion of the investigator, would significantly decrease obtaining reliable data, achieving study objectives or completing the study
boolean
C3843040 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C3858758 (UMLS CUI [1,3])
C0681873 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C2985627 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C2348577 (UMLS CUI [3,3])
C0680082 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C3858758 (UMLS CUI [4,3])
C0681873 (UMLS CUI [4,4])
C0680082 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C2985627 (UMLS CUI [5,3])
C0680082 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C2348577 (UMLS CUI [6,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial